Moderna and Drug Discovery With AI

Moderna and Drug Discovery With AI

Up next

Cambridge Consultants on AI-Powered Deep Tech

AI could sharply accelerate deep-tech innovation, but companies’ ability to turn that acceleration into commercial advantage may depend more on capital allocation, leadership and organizational structure than the technology itself. Cambridge Consultants CEO Richard Traherne and C ...  Show more

WEKA on Rebuilding Storage for the Agentic Era

“Five years from now, the most important thing about AI storage is going to be… that it’ll not look like storage,” says WEKA co-founder and CEO Liran Zvibel. He joins Bloomberg Intelligence’s Derek Mogull to discuss how WEKA was built from the ground up for high-performance AI wo ...  Show more

Recommended Episodes

How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264
NVIDIA AI Podcast

Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies ...  Show more

Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230
NVIDIA AI Podcast

Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Rec ...  Show more

How CytoReason is Bridging the Data Insight Gap to Accelerate Healthcare Breakthroughs - Ep. 276
NVIDIA AI Podcast

Shai Shen-Orr, co-founder and chief scientist at CytoReason and professor at the Technion, talks about the next frontier in healthcare: disease modeling. Shai shares how CytoReason bridges the gap between exploding biological data and actionable insight, powering smarter, faster ...  Show more